ČEŠKOVÁ, Eva, Radovan PŘIKRYL, Tomáš KAŠPÁREK a Marta ONDRUŠOVÁ. Prolactin levels in risperidone treatment of first episode schizophrenia. International Journal of Psychiatry in Clinical Practice. 2003, roč. 2003, č. 8, s. 1-6. ISSN 1365-1501.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Prolactin levels in risperidone treatment of first episode schizophrenia.
Název anglicky Prolactin levels in risperidone treatment of first episode schizophrenia.
Autoři ČEŠKOVÁ, Eva (203 Česká republika, garant), Radovan PŘIKRYL (203 Česká republika), Tomáš KAŠPÁREK (203 Česká republika) a Marta ONDRUŠOVÁ (203 Česká republika).
Vydání International Journal of Psychiatry in Clinical Practice, 2003, 1365-1501.
Další údaje
Originální jazyk čeština
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 0.191
Kód RIV RIV/00216224:14110/03:00021237
Organizační jednotka Lékařská fakulta
UT WoS 000220242100006
Klíčová slova anglicky prolactin; risperidone; schizophrenia
Štítky prolactin, risperidone, schizophrenia
Změnil Změnila: prof. MUDr. Eva Češková, CSc., učo 726. Změněno: 23. 6. 2009 11:23.
Anotace
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
Anotace anglicky
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
VytisknoutZobrazeno: 2. 5. 2024 02:59